Company intelligence / Profile preview

Medeologix

San Jose, California, United States

Ownership: Private
Development stage: Other

Overview

Medeologix, through its subsidiaries, supplies advanced device components and complete minimally invasive devices (such as catheters and balloons) for global MedTech clients, and supports pilot production for clinical trials as well as full-scale commercialization across multiple therapeutic areas. Clinical trials are conducted by its group companies for minimally invasive medical device platforms targeted at BPH and other indications, with reported positive safety and feasibility readouts for the XFLO Expander system.

Therapeutic areas: CardiovascularOphthalmologyGastroenterologyNeurologyMen's Health
Modalities: DeviceCatheterMedical tubingBalloon technologyHydrophilic coating
Industry: Surgical Medical Devices

Partnerships

Biocoat (hydrophilic coating services partner)

Beyond the preview

Go deeper on Medeologix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medeologix.

Explore the full profile